Explore Business Standard
Associate Sponsors
Co-sponsor
Promising advance in depression research
New Delhi, Apr 10 (ANI): A recent study suggests that a particular protein, GPR56, is involved in the biology of depression and the effect of antidepressants. The researchers believe that this protein could offer a novel target for new antidepressant drugs. Depression is a common psychiatric disorder and one of the leading causes of disability worldwide. Antidepressants are the first-line treatment for moderate to severe major depressive episodes. Despite their effectiveness, only 40% of patients respond to the first antidepressant they try. Mental illness associated with the risk of addiction and an increased risk of suicide.